Press Releases

The Board of Directors of the Foundation for the National Institutes of Health (FNIH) has unanimously elected Board member Steven M. Paul, M.D., as the new Chairman. Dr. Paul’s term began immediately following the May 19, 2016 Board meeting. Dr. Paul succeeds Charles A. Sanders, M.D., who has served as Chairman since 1997 and will remain a member of the Board. In addition, Thomas R. Insel, M.D., and Paul Stoffels, M.D., were elected as new Board members.

The Foundation for the National Institutes of Health (FNIH) has selected Jeannie T. Lee, M.D., Ph.D., as the 2016 winner of the Lurie Prize in Biomedical Sciences for uncovering the functions of long, noncoding RNA (lncRNA) in epigenetic regulation.

Today, the Foundation for the National Institutes of Health (FNIH) announced the results from a three-year research study that prioritizes and advances the best biological markers (biomarkers) to measure and predict structural changes and treatment responses in osteoarthritis (OA)—one of the most prevalent and disabling diseases in the world.

The Congress of Neurological Surgeons (CNS), with the Foundation for the National Institutes of Health (FNIH), today announced that the CNS will contribute $200,000 in funding to an ongoing NINDS national career development program to support an additional early career neurosurgeon, competitively selected as the National Institute of Neurological Disorders and Stroke—Congress of Neurological Surgeons Getch Scholar (NINDS/CNS Getch Scholar).

The Foundation for the National Institutes of Health (FNIH) announced today a public-private collaboration with the National Institute of Mental Health (NIMH), a component of the National Institutes of Health, and the Simons Foundation Autism Research Initiative (SFARI), among others.

The Board of Directors of the Foundation for the National Institutes of Health (FNIH) has unanimously elected Russell W. Steenberg as a Director of the Foundation. His three-year term began immediately after the May 21 Board meeting.

The Board of Directors of the Foundation for the National Institutes of Health (FNIH) has unanimously elected Judy Lansing Kovler, Ph.D., as a Director of the Foundation. Her three-year term began immediately after the May 21 Board meeting.

The Foundation for the National Institutes of Health (FNIH) is pleased to announce a workshop and progress update on the Osteoarthritis Biomarkers Consortium Project, which will be held immediately before the opening plenary session of the World Congress on Osteoarthritis in Seattle on April 30.

The Foundation for the National Institutes of Health (FNIH) will award more than $3 and a half million to further the study of Type 2 Diabetes (T2D) as part of an unprecedented collaboration to develop new ways to diagnose and treat several pressing diseases.

The Foundation for the National Institutes of Health (FNIH) has selected Karl Deisseroth, M.D., Ph.D., as the 2015 winner of the Lurie Prize in Biomedical Sciences for the development of optogenetics and CLARITY as tools to study the functions of cells, especially neurons. Dr. Deisseroth is being recognized for leading the development of optogenetics, a technology for controlling cells with light to determine function, as well as for CLARITY, a method for transforming intact organs into transparent polymer gels to allow visualization of biological structures with high resolution and detail. The Lurie Prize will be presented to Dr. Deisseroth on May 20, 2015 in Washington, D.C.

FNIH on Twitter